Focusing specifically on MSCPD-related gene prognostic modeling, our work not only confirms the clinical significance of four pivotal genes (including MS4A2) across multiple TCGA and GEO cohorts, but also uncovers a unique tumor progression mechanism mediated through mesenchymal-epithelial transition regulation. Here, MS4A2 is linked to neoplasm.